Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05160675 Active, not recruiting - Healthy Clinical Trials

Nutrition, Microbiome and Bone Health During Early Life Related to Health

Bamboo
Start date: September 3, 2021
Phase:
Study type: Observational

The aim of the study is to establish the longitudinal microbiome and bone trajectories from birth to 3 years, and to evaluate the influence of nutrition on these trajectories.

NCT ID: NCT05151653 Active, not recruiting - Healthy Clinical Trials

A Study to Test How Well Healthy Men Tolerate BI 765250 When Given as an Infusion Into the Vein or as an Injection Under the Skin

Start date: January 20, 2022
Phase: Phase 1
Study type: Interventional

The main objectives of this trial are to investigate safety, tolerability, pharmacokinetics and pharmacodynamics following single rising doses of BI 765250.

NCT ID: NCT05144022 Active, not recruiting - Healthy Clinical Trials

Multi-level Molecular Profiling of High Acute Stress: a Clinical Study

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

Although it is well known that stress plays an important role in the development of neuropsychiatric diseases, the precise role and molecular effects of stress have only been poorly understood. For example, autophagy is essential for energy and cellular homeostasis through protein catabolism, and dysregulation results in compromised proteostasis, stress-coping behavior, and excessive secretion of signaling molecules and inflammatory factors. Therefore, the aim of the project is to analyze the clinical effects of a bungee jump resembling an acute stress event in correlation to autophagy and other underlying, multi-level molecular profiling. Specifically, it is planned to perform multi-level molecular profiling and sleep analysis in a cohort of healthy male individuals before, during, and after a bungee jump compared to a control cohort of healthy males not undergoing a stress event. The resulting findings will advance the role of autophagy during the stress response and hence in the development of psychiatric disorders, and possibly investigate alternative treatment venues on a molecular level, and finally contribute to a better clinical outcome.

NCT ID: NCT05135169 Active, not recruiting - Healthy Clinical Trials

Multi-organ Transit Time Acquisition Using Contrast Ultrasound

Start date: March 3, 2022
Phase:
Study type: Observational

Echocardiographic contrast will be administered to volunteers for the purpose of measuring transit time through various organs/vascular beds

NCT ID: NCT05125211 Active, not recruiting - Healthy Clinical Trials

Safety,Tolerability,and Pharmacokinetics Profiles of GB001 Recombinant Peptide Spray in Healthy Subjects

Start date: August 8, 2022
Phase: Phase 1
Study type: Interventional

This trial is conducted in China. The aim of this clinical trial is to assess the safety , tolerability and pharmacokinetics profiles of GB001 by single ascending dose and multiple ascending doses in healthy subjects after topical buccal delivery.

NCT ID: NCT05117437 Active, not recruiting - Healthy Clinical Trials

The Effect Of Anaerobic Exercise On Bone Morphogenetic Protein 9

Start date: December 3, 2020
Phase:
Study type: Observational

Bone morphogenetic protein (BMP) 9 from the BMP family has an important role in the remodeling of bone and cartilage. Due to these features, BMP9 can play an important role in especially anaerobic exercise training adaptations. However, the role of anaerobic exercise in these effects is still unclear. The aim of this study is to investigate the role of BMP9 on the effects of acute and chronic anaerobic exercise on bone metabolism markers. Postprandial venous blood samples were taken pre- and post- acute YOYO intermittent recovery test (level 1) in 40 trained male athletes aged 18-35 who did anaerobic sports (such as basketball, volleyball and handball) and 41 sedentary volunteers aged 18-35. Serum BMP9, as markers of bone formation and resorption; alkaline phosphatase (ALP), C-terminal telopeptide of type 1 collagen (CTX1), cartilage oligomeric matrix protein (COMP) and calcium levels were determined. The data to be obtained as a result of our study can give information about the relationship between the skeletal and bone health of the athletes and anaerobic exercise.

NCT ID: NCT05114252 Active, not recruiting - Healthy Clinical Trials

Amblyopia and Stereoptic Games for Vision

AMBER
Start date: December 6, 2022
Phase: N/A
Study type: Interventional

Amblyopia is the most common developmental vision disorder in children, caused by abnormal visual experience in early life, especially a difference in refraction between the eyes, a misalignment of the eye axes, a combination of both. Besides a significant reduced visual acuity, the patients show deficits in 3D vision and functional vision impairment like reduced reading speed, selective attention or motor control skills. The gold standard treatment for amblyopia, occlusion therapy, can lead to relapses or residual amblyopia (i.e., amblyopia that persist into adulthood). The current study aims to test the efficacy of a novel home-based child-friendly rehabilitation program for amblyopia, Vivid Vision Home, involving playing serious videogames on a virtual reality (VR) headset at home. The VR training will be compared to standard care (wearing a spectacle correction) and to age-matched typically developing individuals. A cross-over design will be used so that each participant will receive both treatments (games, spectacles). There is a growing number of studies showing benefits of binocular stimulation for visual acuity and stereovision, but provided mainly by level III studies, with a need for rigorous level I or II studies, using more engaging therapies, to confirm or refute the efficacy of this approach as an adjunct or replacement for current amblyopia treatments. Embedding binocular stimulation in engaging, immersive serious games delivered on VR headsets at home, as implemented by Vivid Vision Home, can address this question.

NCT ID: NCT05112939 Active, not recruiting - Healthy Clinical Trials

A Study of a Rilpivirine Extended-Release Suspension in Healthy Participants

Start date: November 16, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to characterize the single dose pharmacokinetics (PK) and evaluate the safety and tolerability of subcutaneous administration of rilpivirine (RPV) long-acting (LA) or RPV LA in combination with cabotegravir (CAB) LA extended release suspensions in different conditions in healthy adult participants.

NCT ID: NCT05065008 Active, not recruiting - Healthy Clinical Trials

The Roles of Gut Microbiome in UTI Susceptible Women

Start date: October 18, 2021
Phase: N/A
Study type: Interventional

Clinical trials on cranberry juice and UTI prevention yielded both positive and negative results for unknown reason. Gut microbiome in women affect the absorption and metabolism of cranberry bioactives. The variation of gut microbiome is a probable mechanism for metabolic polymorphisms and disparity in UTI prevention in women.

NCT ID: NCT05023070 Active, not recruiting - Healthy Clinical Trials

Investigation of the Pharmacokinetic Profile of CBD

Start date: July 22, 2021
Phase: Phase 1
Study type: Interventional

The goal of the current study is to evaluate the bioavaibiltiy of CBD in normal healthy Individuals. This is an open cross-over design study in healthy individuals to assess the safety and pharmacokinetic (PK) effects of cannabidiol.